Stay updated on Belantamab Mafodotin Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin Combo in Myeloma Clinical Trial page.

Latest updates to the Belantamab Mafodotin Combo in Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe study record history now shows Revision: v3.6.4, replacing the previous revision, indicating a new version of the page history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe record history gains a new release note label 'Revision: v3.6.3' and an additional item 'Results Submission Events (1)', indicating a platform update to the history data.SummaryDifference0.2%

- Check30 days agoChange DetectedThe study history now includes a new revision entry (v3.6.2) and the previous revision (v3.6.0) was removed from the history, reflecting an update to the record's release history.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded the statement 'No longer looking for participants' to indicate that recruitment has ended. Updated the revision history to 'Revision: v3.6.0' and removed the previous 'Revision: v3.5.5' entry.SummaryDifference0.3%

- Check51 days agoChange DetectedVersion 3.5.5 is added with Results Submitted, replacing No Results Posted in the history; the history now reflects that trial results have been submitted.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry (v3.5.4) was added to the record history, and the previous entry (v3.5.3) was removed. This reflects a minor site release updating the history metadata.SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin Combo in Myeloma Clinical Trial page.